Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for 10x Genomics (TXG : NSDQ)

• Company Description    10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. Number of Employees: 410

• Price / Volume Information    Yesterday's Closing Price: $16.49 Daily Weekly Monthly 20 Day Moving Average: 1,916,845 shares Shares Outstanding: 126.55 (millions) Market Capitalization: $2,086.86 (millions) Beta: 2.14 52 Week High: $20.34 52 Week Low: $6.78 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -12.33% -13.36% 12 Week 29.33% 25.34% Year To Date 14.83% -2.54%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 6230 STONERIDGE MALL ROAD - PLEASANTON,CA 94588 USA ph: 925-401-7300 fax: - investors@10xgenomics.com http://www.10xgenomics.com

• General Corporate Information    Officers Serge Saxonov - Chief Executive Officer and Director John R. Stuelpnagel - Chairman Benjamin J. Hindson - President Adam S. Taich - Chief Financial Officer Sridhar Kosaraju - Director Peer Information 10x Genomics (HLIS) 10x Genomics (AZTA) 10x Genomics (APYI) 10x Genomics (RNVA) 10x Genomics (HMSY) 10x Genomics (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 88025U109 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/11/26 Share - Related Items Shares Outstanding: 126.55 Most Recent Split Date: (:1) Beta: 2.14 Market Capitalization: $2,086.86 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.20 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.80 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 55.94% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.66 Price/Cash Flow: - Price / Sales: 3.25 EPS Growth vs. Year Ago Period: 26.67% vs. Previous Quarter: -178.57% Sales Growth vs. Year Ago Period: -1.75% vs. Previous Quarter: -13.83% ROE 09/30/25 - -11.50 06/30/25 - -12.88 03/31/25 - -23.22 ROA 09/30/25 - -8.93 06/30/25 - -10.03 03/31/25 - -18.02 Current Ratio 09/30/25 - 4.48 06/30/25 - 5.84 03/31/25 - 5.37 Quick Ratio 09/30/25 - 4.06 06/30/25 - 5.23 03/31/25 - 4.68 Operating Margin 09/30/25 - -13.32 06/30/25 - -14.56 03/31/25 - -26.61 Net Margin 09/30/25 - -11.89 06/30/25 - -13.13 03/31/25 - -25.14 Pre-Tax Margin 09/30/25 - -11.39 06/30/25 - -12.31 03/31/25 - -24.56 Book Value 09/30/25 - 6.20 06/30/25 - 6.76 03/31/25 - 5.78 Inventory Turnover 09/30/25 - 2.77 06/30/25 - 2.45 03/31/25 - 2.32 Debt-to-Equity 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©